Click to Translate to English Click to Translate to French  Click to Translate to Spanish  Click to Translate to German  Click to Translate to Italian  Click to Translate to Japanese  Click to Translate to Chinese Simplified  Click to Translate to Korean  Click to Translate to Arabic  Click to Translate to Russian  Click to Translate to Portuguese  Click to Translate to Myanmar (Burmese)

PANDEMIC ALERT LEVEL
123456
Forum Home Forum Home > Main Forums > Latest News
  New Posts New Posts RSS Feed - Genetic damage and Covid19
  FAQ FAQ  Forum Search   Events   Register Register  Login Login

Tracking the next pandemic: Avian Flu Talk

Genetic damage and Covid19

 Post Reply Post Reply
Author
Message
Dutch Josh View Drop Down
Adviser Group
Adviser Group


Joined: May 01 2013
Location: Arnhem-Netherla
Status: Offline
Points: 95777
Post Options Post Options   Thanks (0) Thanks(0)   Quote Dutch Josh Quote  Post ReplyReply Direct Link To This Post Topic: Genetic damage and Covid19
    Posted: July 24 2020 at 11:12pm

DJ-Men have XY chromosomes. If on the X there is genetic information to deal with fighting infections damage on that one X chromosome may mean men are more likely to get more infected/have less defenses. (Women have XX chromosomes-if one X does have a problem the other X can deal with that.) 

[url]https://jamanetwork.com/journals/jama/fullarticle/2768926[/url];

Key Points

Question  Are genetic variants associated with severe coronavirus disease 2019 (COVID-19) in young male patients?

Findings  In a case series that included 4 young male patients with severe COVID-19 from 2 families, rare loss-of-function variants of the X-chromosomal TLR7 were identified, with immunological defects in type I and II interferon production.

Meaning  These findings provide insights into the pathogenesis of COVID-19.

Abstract

Importance  Severe coronavirus disease 2019 (COVID-19) can occur in younger, predominantly male, patients without preexisting medical conditions. Some individuals may have primary immunodeficiencies that predispose to severe infections caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Objective  To explore the presence of genetic variants associated with primary immunodeficiencies among young patients with COVID-19.

Design, Setting, and Participants  Case series of pairs of brothers without medical history meeting the selection criteria of young (age <35 years) brother pairs admitted to the intensive care unit (ICU) due to severe COVID-19. Four men from 2 unrelated families were admitted to the ICUs of 4 hospitals in the Netherlands between March 23 and April 12, 2020. The final date of follow-up was May 16, 2020. Available family members were included for genetic variant segregation analysis and as controls for functional experiments.

Exposure  Severe COVID-19.

Main Outcome and Measures  Results of rapid clinical whole-exome sequencing, performed to identify a potential monogenic cause. Subsequently, basic genetic and immunological tests were performed in primary immune cells isolated from the patients and family members to characterize any immune defects.

Results  The 4 male patients had a mean age of 26 years (range, 21-32), with no history of major chronic disease. They were previously well before developing respiratory insufficiency due to severe COVID-19, requiring mechanical ventilation in the ICU. The mean duration of ventilatory support was 10 days (range, 9-11); the mean duration of ICU stay was 13 days (range, 10-16). One patient died. Rapid clinical whole-exome sequencing of the patients and segregation in available family members identified loss-of-function variants of the X-chromosomal TLR7.

We cannot solve our problems with the same thinking we used when we created them.
~Albert Einstein
Back to Top
Dutch Josh View Drop Down
Adviser Group
Adviser Group


Joined: May 01 2013
Location: Arnhem-Netherla
Status: Offline
Points: 95777
Post Options Post Options   Thanks (0) Thanks(0)   Quote Dutch Josh Quote  Post ReplyReply Direct Link To This Post Posted: July 24 2020 at 11:17pm

An April 28 study also looked at genetic differences;

[url]https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186185/[/url];

COVID-19 pandemic: is a gender-defined dosage effect responsible for the high mortality rate among males?

Humankind is currently confronting a new type of coronavirus, and it may take considerable time before the human population and the virus arrive at a mutual equilibrium. The first patients with coronavirus disease 2019 (COVID-19) were recorded in December 2019 in China (Zhu et al. 2020), and since then the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally. Other reputed members of the coronavirus family are SARS-CoV-1 and MERS-CoV, which caused zoonotic events that resulted in epidemics in 2002 and 2012, respectively (Peiris et al. 2003; Zaki et al. 2012). According to the WHO (22/4/2020), more than 2,400,000 individuals have been infected by SARS-CoV-2, and at least 165,000 have succumbed to the disease (https://covid19.who.int). Most patients with COVID-19 suffer from severe respiratory problems, and elderly people in particular or persons with comorbidities seem to be at greatest risk (Wang et al. 2020). The fatality rates for males are two to three times higher than for females (Porcheddu et al. 2020), but seem to fluctuate depending on the territory and demography of the population. Gender-related social factors, immunological differences, hormonal disparaties, and lifestyle habits such as smoking and alcohol consumption are considered to play a role (Wenham et al. 2020). The vulnerability of the male population with regard to the COVID-19 pandemic may to some extent be a result of gender-defined genetic polymorphisms.

At least two coronaviruses use Angiotensin Converting Enzyme 2 as port of entry (ACE-2) to infect the host (Hoffmann et al. 2020; Kuba et al. 2005). ACE2 plays an important role in controlling blood pressure and regulating cardiac function, and is abundantly present on the epithelial cells of the lung, heart, blood vessels, kidneys, and intestines. Although the gene for ACE2 is located on the female sex chromosome, its location and polymorphisms do not seem to have had a bearing on the poor prognosis for male patients during the SARS-CoV-1 epidemic (Chiu et al. 2004).

We cannot solve our problems with the same thinking we used when we created them.
~Albert Einstein
Back to Top
 Post Reply Post Reply
  Share Topic   

Forum Jump Forum Permissions View Drop Down